These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26471208)

  • 1. HDAC expression and activity is upregulated in diseased lupus-prone mice.
    Regna NL; Vieson MD; Gojmerac AM; Luo XM; Caudell DL; Reilly CM
    Int Immunopharmacol; 2015 Dec; 29(2):494-503. PubMed ID: 26471208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice.
    Hu N; Long H; Zhao M; Yin H; Lu Q
    Scand J Rheumatol; 2009; 38(6):464-71. PubMed ID: 19922023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific HDAC6 inhibition by ACY-738 reduces SLE pathogenesis in NZB/W mice.
    Regna NL; Vieson MD; Luo XM; Chafin CB; Puthiyaveetil AG; Hammond SE; Caudell DL; Jarpe MB; Reilly CM
    Clin Immunol; 2016 Jan; 162():58-73. PubMed ID: 26604012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.
    Mishra N; Reilly CM; Brown DR; Ruiz P; Gilkeson GS
    J Clin Invest; 2003 Feb; 111(4):539-52. PubMed ID: 12588892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
    Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
    Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
    Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
    J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus.
    Ren J; Catalina MD; Eden K; Liao X; Read KA; Luo X; McMillan RP; Hulver MW; Jarpe M; Bachali P; Grammer AC; Lipsky PE; Reilly CM
    Front Immunol; 2019; 10():2512. PubMed ID: 31708928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
    Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.
    Ren J; Liao X; Vieson MD; Chen M; Scott R; Kazmierczak J; Luo XM; Reilly CM
    Clin Exp Immunol; 2018 Jan; 191(1):19-31. PubMed ID: 28876451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with a selective histone deacetylase 6 inhibitor decreases lupus nephritis in NZB/W mice.
    Vieson MD; Gojmerac AM; Khan D; Dai R; van Duzer JH; Mazitschek R; Caudell DL; Liao X; Luo XM; Reilly CM
    Histol Histopathol; 2017 Dec; 32(12):1317-1332. PubMed ID: 28245046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability.
    Jochems J; Boulden J; Lee BG; Blendy JA; Jarpe M; Mazitschek R; Van Duzer JH; Jones S; Berton O
    Neuropsychopharmacology; 2014 Jan; 39(2):389-400. PubMed ID: 23954848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fate of immune complexes, glomerulonephritis, and cell-mediated vasculitis in lupus-prone MRL/Mp lpr/lpr mice.
    Cruse JM; Lewis RE; Dilioglou S
    Exp Mol Pathol; 2000 Dec; 69(3):211-22. PubMed ID: 11115362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
    Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
    J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL; Shi GY; Zuo JX; Zhang JW;
    Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.